Physician profile
Kenneth B Ford, JR.
NPI 1518386572
$2,001.32
in general payments reported to CMS, 2019-2025
8 companies · $1,012 in 2025
The $1,012 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.19 · 2023: $486 · 2024: $489 · 2025: $1,012.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,986.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,986.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,020.68 | 2023-2025 | Variax, Mesa Spinal System, Gravity Synchfix |
| Depuy Synthes Sales INC. | $625.87 | 2024-2025 | Na, Va-Lcp, Hammerlock |
| Axogen | $118.07 | 2023 | Avance Nerve Graft |
| Globus Medical, INC. | $116.71 | 2023-2024 | Ankle Fracture System, Distal Femur Plate System, Mini Fragment System |
| Orthalign INC | $51.46 | 2024 | Orthalign Plus |
| Zimmer Biomet Holdings, INC. | $26.94 | 2025 | Persona |
| Pacira Pharmaceuticals Incorporated | $26.40 | 2024 | Exparel |
| Portola Pharmaceuticals, LLC | $15.19 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Ford listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.